After millions upon millions of procedures performed over the span of several decades, the safety of the implants used in breast augmentation and reconstructive surgeries have been thrust to the forefront of thought for both the medical community and the women who underwent the operations. For most women exploring the idea of implants in the late-20th to early-21st centuries, concerns over the procedure were limited to ...
Decades Later, Concern Over Breast Implant Safety Intensifies
Posted July 30, 2020 in Drug and Medical Device Lawsuits | Product News and Recalls
Lawsuit Alleges Textured Breast Implant Cancer Risk Coverup at Allergan
Posted April 6, 2020 in Drug and Medical Device Lawsuits | Product Liability | Product News and Recalls
Much of the initial concern over textured breast implant associated cases of anaplastic large cell lymphoma started out focused on non-U.S. markets. While the vast majority of U.S.-based breast implant procedures utilize smooth implants, the opposite held true for much of the rest of the market.
Six U.S. women who had textured breast implants used in their augmentation procedures have sued Allergan over their increased cancer risk and allege ...
continue reading...Breast Implant Cancer Cases Will Go to Multidistrict Litigation
Posted January 14, 2020 in Product News and Recalls
Approximately 30 lawsuits filed against healthcare goods manufacturer Allergan will be consolidated into a single multidistrict litigation. Plaintiffs in the lawsuits made the request to the Judicial Panel on Multidistrict Litigation over their claims that the company’s breast implant products are responsible for their development or potential development of breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL.
The extraordinarily rare cancer first became ...
continue reading...Dissatisfaction Intensifies Over FDA Inaction on Breast Implant Cancer
Posted June 30, 2019 in Product News and Recalls
Investigations into the growing body of evidence indicating a link between breast implants and a certain type of breast cancer are showing a troubling common thread: a complete lack of warning for the patient over the danger.
Numbers seem to support the notion that the decision to receive breast implants is made without much; if any, concern over personal health. 75 percent of the 400,000 breast implant procedures ...
continue reading...As Women Call for Action, FDA Continues “Assessment” of Breast Implant Cancer Risk
Posted June 13, 2019 in Drug and Medical Device Lawsuits | Product News and Recalls
A growing number of women are being diagnosed with a form of breast cancer linked to breast implants, and the calls for lawsuits and legislative action or regulation are rising.
16 deaths may already be associated with the condition known as BIA-ALCL or breast-implant associated anaplastic large cell lymphoma. U.S. diagnoses of the cancer are now up to 457 from a previous high of 414. ...
continue reading...Breast Implant Safety Draws Renewed Federal Attention
Posted April 2, 2019 in Drug and Medical Device Lawsuits | Product News and Recalls
The long-term safety of breast implants; a topic widely thought to have been resolved over the decades, is receiving renewed interest from medical communities around the world and is now on the radar of the U.S. Food and Drug Administration. What started as concern over a type of cancer predominantly tied to textured breast implants has led to new questions being ...
